Search
for
Sort by
Research 30 of 1000+
- Topical Application of Aprepitant Inhibits Erlotinib-induced Facial Dermatitis/Hair Loss
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth? - eScholarship
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- An overview of management of drug-induced hair and nail disorders
- Dermatologic Adverse Events from Cancer Treatments
- Management of Toxicities of Targeted Therapies
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Current Landscape and Emerging Therapies in Hair Loss Treatment for Androgenetic Alopecia
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Nociceptive and Nonnociceptive Roles of TRPV3 and Its “Druggability”
- Bullous Congenital Ichthyosiform Erythroderma with Tinea Capitis in Half-Siblings: Rare Phenomenon in Ichthyosis with Co-Existing Trichophyton rubrum Infection and Blocker Displacement Amplification for Mosaic Mutation Detection
- Persistent hair growth during treatment with the EGFR inhibitor erlotinib
- Epidermal Growth Factor as a Biologic Switch in Hair Growth Cycle
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth?
- Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor
- Dacomitinib-Induced Paronychia Associated With PRIDE Syndrome in a Patient With Non-Small Cell Lung Cancer
- Hair & Cutaneous Development
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- Malignant epithelial tumors: Part II. Therapy and prevention
- Oral medications for central serous chorioretinopathy: a literature review
- Androgen effects on the skin
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- The Roles of Keratinocytes in the Initiation, Progression and Maintenance of Hidradenitis Suppurativa
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Cutaneous drug reactions
- Pharmacological Activation of Thermo–Transient Receptor Potential Vanilloid 3 Channels Inhibits Hair Growth by Inducing Cell Death of Hair Follicle Outer Root Sheath
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Drug-Induced Skin, Nail and Hair Disorders